Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 228 | $116,134,138 |
Sells | 4 | $198,660,583 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 02 Jun 2022 | Purchase | 138,122 | 7.6793 | 1,060,680 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 1,740,581 | 0.6308 | 1,097,958 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 8,098 | 153.9736 | 1,246,878 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 5,594 | 224.9117 | 1,258,156 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 7,010 | 183.3999 | 1,285,633 | I |
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 06 Jun 2022 | Purchase | 170,549 | 7.7808 | 1,327,008 | I |
15 Dec 2023 17:32 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Dec 2023 | Purchase | 214,025 | 6.6 | 1,412,565 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 7,917 | 190.1361 | 1,505,308 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 10,790 | 141.445 | 1,526,192 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 10,715 | 175.8179 | 1,883,889 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 74,582 | 25.54 | 1,904,824 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 82,148 | 24.4604 | 2,009,373 | I |
28 Mar 2024 19:04 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 26 Mar 2024 | Purchase | 247,656 | 8.2621 | 2,046,159 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 9,262 | 222.676 | 2,062,425 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 13,548 | 154.7801 | 2,096,961 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 10,264 | 216.6994 | 2,224,203 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 15 Nov 2023 | Purchase | 14,018 | 161.966 | 2,270,439 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 10,894 | 217.5152 | 2,369,611 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 13,011 | 188.3232 | 2,450,273 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 13,505 | 188.4649 | 2,545,218 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 11,602 | 227.857 | 2,643,597 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 15,620 | 188.7029 | 2,947,539 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 116,672 | 25.3302 | 2,955,325 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 18,125 | 174.8748 | 3,169,606 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 15,005 | 219.241 | 3,289,711 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 26,426 | 146.2104 | 3,863,756 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 31,530 | 156.4244 | 4,932,061 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 218,171 | 25.2723 | 5,513,683 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 29,738 | 218.4583 | 6,496,513 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 259,109 | 25.65 | 6,646,146 | I |
14 Nov 2023 17:54 | BGNE | BeiGene Ltd. | BAKER BROS. ADVISORS LP | Director , 10% | 14 Nov 2023 | Sale | 91,340 | 180.5 | 16,486,870 | I |
14 Nov 2023 17:54 | BGNE | BeiGene Ltd. | BAKER BROS. ADVISORS LP | Director , 10% | 14 Nov 2023 | Sale | 1,008,660 | 180.5 | 182,063,130 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)